{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:11:18Z","timestamp":1793200278155,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40257-021-00633-4","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:02:50Z","timestamp":1630508570000},"page":"829-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation"],"prefix":"10.1007","volume":"22","author":[{"given":"Nada","family":"Elbuluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelani","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"633_CR1","first-page":"33","volume":"21","author":"AF Alexis","year":"2009","unstructured":"Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs. 2009;21:33\u20136.","journal-title":"Dermatol Nurs"},{"issue":"609\u201315","key":"633_CR2","first-page":"vii","volume":"21","author":"RM Halder","year":"2003","unstructured":"Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(609\u201315):vii.","journal-title":"Dermatol Clin"},{"issue":"388","key":"633_CR3","first-page":"390","volume":"32","author":"RM Halder","year":"1983","unstructured":"Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(388):390.","journal-title":"Cutis"},{"key":"633_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0733-8635(03)00075-5","volume":"21","author":"SC Taylor","year":"2003","unstructured":"Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin. 2003;21:601\u20137.","journal-title":"Dermatol Clin"},{"issue":"7","key":"633_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/1346-8138.13263","volume":"43","author":"F Abad-Casintahan","year":"2016","unstructured":"Abad-Casintahan F, Chow SK, Goh CL, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):926\u20138.","journal-title":"J Dermatol"},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/1346-8138.12667","volume":"41","author":"CL Goh","year":"2014","unstructured":"Goh CL, Abad-Casintahan F, Chow SK, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106\u20138.","journal-title":"J Dermatol"},{"issue":"Suppl. 7","key":"633_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jdv.14491","volume":"31","author":"H Gollnick","year":"2017","unstructured":"Gollnick H, Abanmi AA, Al-Enezi M, et al. Managing acne in the Middle East: consensus recommendations. J Eur Acad Dermatol Venereol. 2017;31(Suppl. 7):4\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"633_CR8","first-page":"1","volume":"23","author":"AA Abanmi","year":"2016","unstructured":"Abanmi AA, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi A-G, Zimmo S. Progress and problems with acne management in the Middle East. Gulf J Dermatol Venereol. 2016;23:1\u20135.","journal-title":"Gulf J Dermatol Venereol."},{"key":"633_CR9","first-page":"375","volume":"100","author":"VD Callender","year":"2017","unstructured":"Callender VD, Barbosa V, Burgess CM, et al. Approach to treatment of medical and cosmetic facial concerns in skin of color patients. Cutis. 2017;100:375\u201380.","journal-title":"Cutis"},{"key":"633_CR10","first-page":"401","volume":"13","author":"SJ Kang","year":"2014","unstructured":"Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol. 2014;13:401\u20136.","journal-title":"J Drugs Dermatol"},{"key":"633_CR11","first-page":"466","volume":"11","author":"SA Davis","year":"2012","unstructured":"Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11:466\u201373.","journal-title":"J Drugs Dermatol"},{"key":"633_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2340\/00015555-2164","volume":"96","author":"S Min","year":"2016","unstructured":"Min S, Park SY, Yoon JY, Kwon HH, Suh DH. Fractional microneedling radiofrequency treatment for acne-related post-inflammatory erythema. Acta Derm Venereol. 2016;96:87\u201391.","journal-title":"Acta Derm Venereol"},{"key":"633_CR13","first-page":"566","volume":"16","author":"J Tan","year":"2017","unstructured":"Tan J, Bourdes V, Bissonnette R, et al. Prospective study of pathogenesis of atrophic acne scars and role of macular erythema. J Drugs Dermatol. 2017;16:566\u201372.","journal-title":"J Drugs Dermatol"},{"issue":"Suppl. 1","key":"633_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-4632.2007.03463.x","volume":"46","author":"F Poli","year":"2007","unstructured":"Poli F. Acne on pigmented skin. Int J Dermatol. 2007;46(Suppl. 1):39\u201341.","journal-title":"Int J Dermatol"},{"key":"633_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/CCID.S158129","volume":"11","author":"AO Akinboro","year":"2018","unstructured":"Akinboro AO, Ezejiofor OI, Olanrewaju FO, et al. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol. 2018;11:245\u201352.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"633_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/09546634.2018.1542807","volume":"30","author":"A Abanmi","year":"2019","unstructured":"Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30:578\u201381.","journal-title":"J Dermatolog Treat"},{"key":"633_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2230.1994.tb01200.x","volume":"19","author":"AM Layton","year":"1994","unstructured":"Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl. 1","key":"633_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-4632.2007.03462.x","volume":"46","author":"A Kane","year":"2007","unstructured":"Kane A, Niang SO, Diagne AC, Ly F, Ndiaye B. Epidemiologic, clinical, and therapeutic features of acne in Dakar. Senegal Int J Dermatol. 2007;46(Suppl. 1):36\u20138.","journal-title":"Senegal Int J Dermatol"},{"key":"633_CR19","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"key":"633_CR20","first-page":"27","volume":"6","author":"EA Tanghetti","year":"2013","unstructured":"Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6:27\u201335.","journal-title":"J Clin Aesthet Dermatol"},{"key":"633_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","volume":"121","author":"AH Jeremy","year":"2003","unstructured":"Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20\u20137.","journal-title":"J Invest Dermatol"},{"key":"633_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2133.1988.tb02566.x","volume":"118","author":"JF Norris","year":"1988","unstructured":"Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651\u20139.","journal-title":"Br J Dermatol"},{"key":"633_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2017.01.035","volume":"77","author":"N Silpa-Archa","year":"2017","unstructured":"Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77:591\u2013605.","journal-title":"J Am Acad Dermatol"},{"key":"633_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5812\/ircmj.5358","volume":"15","author":"H Adalatkhah","year":"2013","unstructured":"Adalatkhah H, Sadeghi BH. The association between melasma and postinflammatory hyperpigmentation in acne patients. Iran Red Crescent Med J. 2013;15:400\u20133.","journal-title":"Iran Red Crescent Med J"},{"key":"633_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987100","volume-title":"The pigmentary system: physiology and pathophysiology","author":"JJB Nordlund","year":"2006","unstructured":"Nordlund JJB, Hearing VJ, King RA, Oetting W, Ortonne JP. The pigmentary system: physiology and pathophysiology. Malden: Blackwell Publishing; 2006."},{"key":"633_CR26","first-page":"401","volume":"16","author":"KA Cayce","year":"2004","unstructured":"Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs. 2004;16:401\u20136.","journal-title":"Dermatol Nurs"},{"key":"633_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/bjd.14184","volume":"174","author":"P Isedeh","year":"2016","unstructured":"Isedeh P, Kohli I, Al-Jamal M, et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016;174:862\u20138.","journal-title":"Br J Dermatol"},{"key":"633_CR28","first-page":"219","volume-title":"Thirteenth international pigment","author":"JJA-M Nordlund","year":"1986","unstructured":"Nordlund JJA-M, Abdel-Malek ZA. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara JT, editor. Thirteenth international pigment. Tucson: Liss; 1986. p. 219\u201339."},{"key":"633_CR29","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.3390\/ijms10094066","volume":"10","author":"JP Ebanks","year":"2009","unstructured":"Ebanks JP, Wickett RR, Boissy RE. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci. 2009;10:4066\u201387.","journal-title":"Int J Mol Sci"},{"key":"633_CR30","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms19092668","volume":"19","author":"S Del Bino","year":"2018","unstructured":"Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19:2668.","journal-title":"Int J Mol Sci"},{"key":"633_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.dsi.2014.07.003","volume":"32","author":"JWP Shin","year":"2014","unstructured":"Shin JWP, Park KC. Current clinical use of depigmenting agents. Dermatol Sin. 2014;32:205\u201310.","journal-title":"Dermatol Sin"},{"issue":"7","key":"633_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/ijms17071144","volume":"17","author":"SA D'Mello","year":"2016","unstructured":"D\u2019Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17(7):1144.","journal-title":"Int J Mol Sci"},{"key":"633_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/09546630903401496","volume":"21","author":"SK Shah","year":"2010","unstructured":"Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatol Treat. 2010;21:206\u201311.","journal-title":"J Dermatol Treat"},{"key":"633_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2017.01.036","volume":"77","author":"S Chaowattanapanit","year":"2017","unstructured":"Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017;77:607\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"633_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","volume":"1073","author":"A Palumbo","year":"1991","unstructured":"Palumbo A, d\u2019Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta. 1991;1073:85\u201390.","journal-title":"Biochim Biophys Acta"},{"key":"633_CR36","first-page":"586","volume":"10","author":"LH Kircik","year":"2011","unstructured":"Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586\u201390.","journal-title":"J Drugs Dermatol"},{"key":"633_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/JCAS.JCAS_135_18","volume":"12","author":"R Sarkar","year":"2019","unstructured":"Sarkar R, Ghunawat S, Garg VK. Comparative study of 35% glycolic acid, 20% salicylic-10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation. J Cutan Aesthet Surg. 2019;12:158\u201363.","journal-title":"J Cutan Aesthet Surg"},{"key":"633_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/lsm.20512","volume":"39","author":"HH Chan","year":"2007","unstructured":"Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39:381\u20135.","journal-title":"Lasers Surg Med"},{"issue":"Suppl. 3","key":"633_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/bjd.12526","volume":"169","author":"AF Alexis","year":"2013","unstructured":"Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl. 3):91\u20137.","journal-title":"Br J Dermatol"},{"key":"633_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/lsm.23173","volume":"52","author":"YC Bae","year":"2020","unstructured":"Bae YC, Rettig S, Weiss E, Bernstein L, Geronemus R. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7\u201312.","journal-title":"Lasers Surg Med"},{"key":"633_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2015.12.010","volume":"74","author":"A Haimovic","year":"2016","unstructured":"Haimovic A, Brauer JA, Cindy Bae YS, Geronemus RG. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74:931\u20136.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00633-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T09:52:06Z","timestamp":1635933126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00633-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00633-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Elbuluk has served as a paid consultant and\/or advisory board member for VisualDx, Scientis, Galderma Laboratories LP, Zosana, and Avita; and has received fees for being a Unilever partner. Dr Grimes has served as a consultant for Galderma Laboratories LP, Up-to-Date, and Proctor & Gamble, received grants from Incyte, VT Technologies, Pfizer, Sun, and Arcutis, and has lectures for Scientis (Cyspera). Dr Chien has served as a consultant and\/or advisory board member for Galderma Laboratories LP. Dr Hamzavi has served as a consultant and\/or advisory board member for Galderma Laboratories LP, AbbVie, Incyte, Pfizer, UCB, Boehringer Ingelheim, and Clarify Medical; he has served as an investigator for Pfizer Inc, Bayer, Lenicura, Incyte, Estee Lauder, Ferndale Laboratories, Inc, Galderma Laboratories LP, L\u2019Oreal, Unigen, Arcutis, and Avita; and is Co-Chair of the Global Vitiligo Foundation. Dr Alexis has served as a consultant and\/or advisory board member for Leo, Novartis, Galderma Laboratories LP, Sanofi Regeneron, Dermavent, Unilever, Beiersdorf, Valeant, L\u2019Oreal, Bristol Meyers Squibb, Scientis, Bausch Health, UCB, Arcutis, Janssen, Allergan, Almirall, AbbVie, and Sol-Gel; has served as a speaker for Astra Zeneca; and has received royalties from Springer Verlag, Wiley Blackwell, and Wolters Kluwer. Dr Taylor has served as a consultant, advisory board member, speaker and investigator for Galderma Laboratories LP. Dr Gonzalez has served as a consultant and\/or advisory board member for Galderma Laboratories LP, Neostrata, Exuviance, and Bioderma. Dr Weiss has served as a speaker for Abbvie, Almirall, Galderma Laboratories LP, Ortho Dermatologics, Regeneron and Sanofi; as a consultant and\/or advisory board member for Cassiopia, Cutera Inc, Dr Reddy, EPI Health, Foamix, Galderma Laboratories LP, Incyte, Leo Pharma, Novartis, Ortho Dermatologics, and UCB; and as investigator for AbbVie, Aclaris, Bausch Health, Celgene\/Amgen, Cutera, Endo, Foamix, Galderma Laboratories LP, Leo Pharma, Moberg, and Novartis. Dr Kang has served as a consultant and investigator for Almirall and Galderma Laboratories LP.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Galderma LLP provided funding for editorial services associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"All authors made substantial contributions to the draft work, revised the content critically, and approved the version to be published.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}